Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.

Biotechnology

MiNA Therapeutics

Robert Habib Mba

Susan Clement Davies

Bríd Ryan

Peter Bains

Robin Wright

Troels Koch

The Scientific Team at MiNA Therapeutics is responsible for advancing the research and development of novel gene-activating therapies. Comprising experts in various scientific disciplines, the team designs, conducts, and analyzes preclinical and clinical studies to uncover transformative treatments for severe liver and other diseases. Their work is pivotal in translating MiNA's innovative technology into effective, life-altering medicines.

Scientific Team

Leadership Team

��

Scientific Team

About

Team members

��������

Scientific Team

About

Team members

��